FDA approves new psoriasis drug Taltz - FDA Press Releases

The U.S. Food and Drug Administration today approved Taltz (ixekizumab) to treat adults with moderate-to-severe plaque psoriasis.

from Food and Drug Administration--Press Releases http://ift.tt/1UiS9vF
via IFTTT